Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-01-31

Clinical Trial Update: Effects of Chromium on Insulin Resistance in Alzheimer Disease Patients [NA]

View source ↗

Summary

This document reports a clinical trial update on the effects of chromium on insulin resistance in Alzheimer disease patients. The status of the trial is listed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chromium (Chromium)

Snippet

Sponsor: Metabolic Therapy Inc. | Conditions: Alzheimer Disease | NA | Status: UNKNOWN